Navigation Links
AACR applauds nomination of Francis S. Collins, M.D., Ph.D., to be the new NIH director
Date:7/9/2009

WASHINGTON, D.C. The American Association for Cancer Research applauds President Obama's nomination of Francis S. Collins, M.D., Ph.D., to be the 16th director of the National Institutes of Health (NIH).

"Dr. Collins is an excellent scientist and skillful administrator," said Tyler Jacks, Ph.D., president of the American Association for Cancer Research. "His leadership of the National Human Genome Research Institute and the Human Genome Project has demonstrated his talent for identifying new areas of investigation and his skill in guiding large-scale research endeavors. He has continued and extended this work through collaborations with scientists at the National Cancer Institute on The Cancer Genome Atlas, an effort to understand the genetic basis of the many diseases we call cancer.

"Dr. Collins' vision and leadership will be critical in realizing the promise of cancer research and of biomedical research more generally to revolutionize health care. As we look for innovative ways to help the United States sustain its leadership in medical research, expand training opportunities for the next generation of scientists, and stimulate local and regional economies to create jobs, Dr. Collins' experience and insight will be invaluable," said Jacks.

The AACR looks forward to working with Dr. Collins as new scientific discoveries transform the prevention, diagnosis and treatment of cancer. The AACR urges the Senate to confirm him with haste.


'/>"/>

Contact: Jeremy Moore
jeremy.moore@aacr.org
267-646-0557
American Association for Cancer Research
Source:Eurekalert

Page: 1

Related biology news :

1. Taxpayer Alliance applauds bill to broaden access to federal research results
2. NJIT applauds students for studies on brain injury, glaucoma and more
3. AAAE Applauds Expansion of Registered Traveler Program to Nations Capital
4. SNM applauds NAS study showing need to restore federal nuclear medicine research funding
5. Francisella tularensis: Stopping a biological weapon
6. Geneticist Francis Collins named first recipient of Inamori Ethics Prize at Case Western Reserve
7. DHS Begins Collecting 10 Fingerprints From International Visitors at San Francisco International Airport
8. Georgetown Universitys Howard J. Federoff, M.D., Ph.D. receives Bernard Sanberg Memorial Award
9. Jonathan Berg, M.D., Ph.D. awarded Richard King Trainee Award for Best in Genetics in Medicine
10. Sihoun Hahn, M.D., Ph.D., FACMG is the 2009-2010 Luminex/ACMGF Award recipient
11. BIDMC scientist John Rinn, Ph.D., receives Damon-Runyon Rachleff Innovation Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2016)... 28, 2016 "The biometric ... 16.79%" The biometric system market is in the ... the near future. The biometric system market is expected ... at a CAGR of 16.79% between 2016 and 2022. ... biometric technology in smartphones, rising use of biometric technology ...
(Date:11/22/2016)... , Nov. 22, 2016   MedNet Solutions ... the entire spectrum of clinical research, is pleased to ... Medical LiveWire Healthcare and Life Sciences Awards as ... caps off an unprecedented year of recognition and growth ... for over 15 years. iMedNet ...
(Date:11/17/2016)... Global Market Watch: Primarily supported by ownership types; ... Academics) market is to witness a value of US$37.1 billion ... Compounded Annual Growth Rate (CAGR) of 10.75% is foreseen from ... 2014-2020. North America is not way ... Europe at 9.56% respectively. Report Focus: ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... ... 2016 , ... KBioBox llc announced today the launch of ... a sophisticated “3 click” gene dditing off target analysis program and a “3 ... https://www.kbiobox.com/ and powered by the company’s proprietary BioEngine. Scientists, pharmaceutical researchers ...
(Date:12/8/2016)... , Dec. 8, 2016  Soligenix, Inc. ... biopharmaceutical company focused on developing and commercializing products ... unmet medical need, announced today the long-term follow-up ... SGX942 (dusquetide), a first-in-class Innate Defense Regulator (IDR), ... head and neck cancer patients undergoing chemoradiation therapy ...
(Date:12/8/2016)... , Dec. 8, 2016 Eutilex Co. ... billion KRW (US $18.9M) Series A financing. This financing ... G.N. Tech Venture and SNU Bio Angel. This new ... 30.5 billion KRW (US $27.7M) since its founding in ... to bolster the development and commercialization of its immuno-oncology ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... has concluded that “in the setting of previously treated, advanced pancreatic cancer, liquid ... defining the optimal patient population and timing of blood sampling may improve the ...
Breaking Biology Technology: